Is there a generic for Moexipril hydrochloride?

Yes. The FDA Orange Book lists 4 approved generic (ANDA) applications for Moexipril hydrochloride, referencing the brand UNIVASC. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Moexipril hydrochloride?

UNIVASC (NDA 020312, UCB INC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Moexipril hydrochloride are approved?

Moexipril hydrochloride is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Moexipril hydrochloride

Moexipril hydrochloride is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:UNIVASC · NDA 020312

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
UNIVASC×2	UCB INC	NDA 020312	—	Apr 19, 1995

Generic (ANDA) products (4)

Product	Applicant	Application	TE	Approved
MOEXIPRIL HYDROCHLORIDE×2	GLENMARK PHARMS LTD	ANDA 090416	AB	Mar 30, 2010
MOEXIPRIL HYDROCHLORIDE×2	APOTEX INC	ANDA 078454	—	Jun 02, 2008
MOEXIPRIL HYDROCHLORIDE×2	CHARTWELL RX	ANDA 077536	AB	Nov 30, 2006
MOEXIPRIL HYDROCHLORIDE×2	TEVA	ANDA 076204	AB	May 08, 2003

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Moexipril hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo